MEDBOT-B Granted Listing Approval for Full H-Share Circulation
Stock News
Feb 13
MEDBOT-B (02252) has announced the receipt of approval from the Stock Exchange of Hong Kong, dated February 13, 2026, for the listing and trading of 5.9898 million H-shares. These shares, which are to be converted and listed, represent the total number of non-listed shares involved. The conversion and listing will pertain to an aggregate of 5.9898 million non-listed shares held by two of the company's shareholders, accounting for approximately 0.5808% of the company's total issued share capital as of the announcement date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.